Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2022-07-04

EMA Authorised: Sildenafil Teva (sildenafil) — Teva B.V.

View source ↗

Summary

Authorised erectile dysfunction medicine sildenafil Teva (sildenafil) by Teva B.V. has received approval in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sildenafil Teva (sildenafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Teva B.V.. Decision date: 01/07/2022